Buy LSD in Australia. LSD is one of the most potent, mood-changing chemicals. It was first synthesized in 1938. It is synthetically made from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains.
It is so potent its doses tend to be in the microgram (mcg) range. LSD is produced in crystalline form and then mixed with other inactive ingredients, or diluted as a liquid for production in ingestible forms. It is odorless, colorless, and has a slightly bitter taste.
Its effects, often called a “trip”, can be stimulating, pleasurable, and mind-altering or it can lead to an unpleasant, sometimes terrifying experience called a “bad trip.
LSD is usually found on the streets in various forms, for example:
Blotter paper (LSD soaked onto sheets of absorbent paper with colorful designs; cut into small, individual dosage units) – the most common form
Thin squares of gelatin (commonly referred to as window panes)
Tablet form (usually small tablets known as Microdots) or capsules
Liquid on sugar cubes
The pure liquid form (maybe extremely potent)
What is microdosing?
Microdosing involves taking very low doses of a substance, usually a psychedelic drug. The amount of the substance that is used is significantly below a hallucinogenic dose, yet proponents believe that the practice can produce a range of positive health effects.
The idea of microdosing, at least in its current iteration, can be traced back to the work of James Fadiman, a “transpersonal” psychologist who has studied psychedelics since the early 1960s.
His 2011 book The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys is a near-comprehensive guide to the therapeutic uses of psychedelic compounds such as LSD, psilocybin, and DMT,
and it was this work that began to catalyze a movement around the little dose. Buy LSD in Australia
Microdosing LSD and other hallucinogens initially gained popularity among drug users sharing their experiences on the internet.
Practitioners used online community forums (such as Reddit) and psychedelic information sites’ message boards (like Erowid) to boast about the “benefits” of microdosing
Microdosing with lysergic acid diethylamide (LSD) is associated with improved mood and increased attention, early research suggests
The recent phenomenon of “microdosing” LSD to improve mood and cognitive function has received widespread coverage in the press. But these accounts — mostly self-reported and anecdotal — have not yet been tested with modern clinical research methods.
The use of LSD as an antidepressant in combination with psychotherapy was studied in the 1950s and 1960s, but many of those studies were performed without adequate control groups.
The reviewed studies do not provide robust evidence in favour of a specific dose, but rather give a range in which psychedelics show subtle (beneficial) effects without producing extreme perceptual distortions; for LSD (base) this is between 10 and 20 mcg of LSD
Alleviate mental health symptoms (such as anxiety and depression)
Facilitate social interactions
Reduce physical symptoms (such as muscle tension and headache)
Relieve from menstrual pain
Study in patients with anxiety
An estimated one in ten Australians were taking antidepressants in 2015. That’s double the number using them in 2000, and the second-highest rate of antidepressant use among all OECD countries. Buy LSD in Australia
Gasser and colleagues investigated the safety and efficacy of LSD-psychotherapy in patients with anxiety related to life-threatening diseases. Next to the experimental group who received LSD 200 mcg twice, they included an active control group receiving 20 mcg of LSD.
This low dose was thought to produce short-lived, mild LSD effects that would not substantially facilitate the therapeutic process. Two regular psychotherapy sessions followed each LSD session. The control group entered an open-label crossover to 200 mcg LSD after the treatment blind was broken.
The number frequency and intensity of drug-related adverse events were higher in the high dose condition compared with the low dose condition, though anger, anxiety, and abnormal thinking were more frequent in the low dose condition. LSD did not affect physiological parameters. Self-rated anxiety (trait and state) decreased after two high dose sessions with LSD – an effect that was sustained up to 12 months after treatment. In the low dose group, however, anxiety increased after two sessions with LSD 20 mcg and decreased after the open-label crossover to LSD 200 mcg – an effect that was also measurable at 12 months follow-up. Of note, the total sample size was very small, and the low dose was only given to three participants. The authors noted correctly that the (fluctuating) medical conditions of the participants could have influenced the psychological state; hence, the self-rated anxiety.39 While the data seem to suggest a low dose of LSD does not support the therapeutic process, this study did not aim to test this hypothesis, and future studies in larger samples should corroborate this.